Killer cell Ig-like receptor (KIR) 3DL1 down-regulation enhances inhibition of type 1 diabetes by autoantigen-specific regulatory T cells.
Both Foxp3(+) regulatory T cells (Tregs) and antigen-expanded Foxp3(-) Tregs play an important role in regulating immune responses as well as in preventing autoimmune diseases and graft rejection. Molecular mechanisms modulating Treg function remain largely unclear, however. We report here on the expression and function of an inhibitory killer cell Ig-like receptor, KIR3DL1, in a nonobese diabetic (NOD) mouse-derived autoantigen-specific Treg (2D2), which protects from type 1 diabetes (T1D) in adoptive transfer experiments. This gene is not expressed in T1D pathogenic T cells (Tpaths) or non-Tpath T cells. KIR genes are known to play an important role in regulating natural killer (NK) cell function, but their role in Tregs and T1D is unknown. To examine whether KIR3DL1 expression may modulate Treg function, we used shRNA to down-regulate KIR3DL1 expression (2D2-shKIR). We find that KIR3DL1 down-regulation enhances in vitro function, as measured by improved suppression of target cell proliferation. Antibody blockade of IL-10 but not IL-4 partially abrogated suppressive function. In vivo function is also improved. Adoptive transfer of 2D2-shKIR into 10-wk-old NOD mice prevented spontaneous insulitis and T1D, and the inhibitory effect was further improved if the cells were transferred earlier into 6-wk-old NOD mice. These studies indicate that KIR3DL1 expression may negatively regulate Treg function and suggest a previously undescribed target for improving immune tolerance for potential treatment of autoimmune diseases like T1D.
Department of Immunology, Diabetes and Metabolic Disease Research, The Beckman Research Institute of the City of Hope, Duarte, CA 91010-3000, USA.
Hanjun
H
Qin
Zunde
Z
Wang
Weiting
W
Du
Wen-Hui
WH
Lee
Xiwei
X
Wu
Arthur D
AD
Riggs
Chih-Pin
CP
Liu
D000818:Animals; D001324:Autoantigens / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology*; D015536:Down-Regulation; D055785:Gene Knockdown Techniques; D051379:Mice; D016688:Mice, Inbred NOD; D054340:Receptors, KIR / Q000235:genetics / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
D001324:Autoantigens; D054340:Receptors, KIR
Trends Immunol. 2007 Oct;28(10):437-41
17825623
J Exp Med. 2004 Jun 7;199(11):1467-77
15184500
Arthritis Rheum. 2004 Sep;50(9):2721-4
15457438
Annu Rev Immunol. 2005;23:225-74
15771571
Curr Opin Immunol. 2004 Oct;16(5):626-33
15342010
Semin Immunol. 2006 Apr;18(2):103-10
16458533
Blood. 2009 Oct 15;114(16):3422-30
19628706
Nature. 1997 Oct 16;389(6652):737-42
9338786
Immunol Rev. 2008 Aug;224:85-97
18759922
Cancer Res. 2003 Nov 1;63(21):7475-82
14612548
Annu Rev Immunol. 2002;20:853-85
11861620
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8213-8
12034883
Nat Immunol. 2005 Apr;6(4):338-44
15785759
Arthritis Res Ther. 2008;10 Suppl 1:S3
19007423
Annu Rev Immunol. 2004;22:531-62
15032588
Immunol Rev. 2001 Jun;181:223-33
11513144
Annu Rev Immunol. 2002;20:217-51
11861603
Nat Genet. 2002 Aug;31(4):429-34
12134147
Nat Immunol. 2001 May;2(5):430-5
11323697
J Allergy Clin Immunol. 2000 Jul;106(1 Pt 2):S109-12
10887343
Clin Immunol. 2009 Feb;130(2):213-24
18945643
EMBO J. 2004 Jan 28;23(2):255-9
14685277
Blood. 2005 Mar 15;105(6):2594-600
15536148
J Immunol. 2004 Dec 1;173(11):6777-85
15557171
J Immunol. 1997 Jun 1;158(11):5237-41
9164941
Cell. 1993 Sep 24;74(6):1089-100
8402882
J Exp Med. 2004 Jun 7;199(11):1455-65
15184499
Immunogenetics. 2007 Aug;59(8):641-51
17516061
J Exp Med. 2005 Apr 4;201(7):1025-9
15809348
J Immunol. 2009 Sep 1;183(5):3481-7
19675166
Curr Mol Med. 2006 Sep;6(6):621-9
17022732
J Immunol. 2003 Apr 15;170(8):4011-20
12682229
Annu Rev Immunol. 2006;24:209-26
16551248
Clin Immunol. 2009 Aug;132(2):257-65
19394279
Nat Med. 2004 Aug;10(8):801-5
15286781
J Immunol. 2003 Jul 15;171(2):733-44
12847240
J Immunol. 2006 Mar 15;176(6):3449-60
16517713
PLoS One. 2009 Nov 17;4(11):e7863
19924236
J Immunol. 1998 Jun 1;160(11):5239-45
9605119
J Immunol. 2001 Mar 15;166(6):3923-32
11238637
Mol Ther. 2003 Aug;8(2):324-31
12907155
Immunol Rev. 2008 Aug;224:58-69
18759920